NUVB
insider transactionsNuvation Bio Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-1.2M
25.0K buy · 1.2M sell
Net value · 365d
-$7.4M
$118.2K in · $7.6M out
Sentiment · 365d
Net selling
2% buying · 98% selling
Open-market trades · 365d
14
25.0K buy · 1.2M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Buy·P
Director
$118.2K
25.0K sh · $4.73
Own +12%
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Exercise·M
CHIEF REGULATORY OFFICER · 10b5-1
$0
36.8K sh
Own +21%
-
Sell·S
CHIEF REGULATORY OFFICER · 10b5-1
$184.3K
36.8K sh · $5.01
Own -41%
-
Exercise·M
CHIEF REGULATORY OFFICER · 10b5-1
$107.7K
36.8K sh · $2.93
Own +69%
-
Exercise·M
CHIEF MEDICAL OFFICER · 10b5-1
$0
50.0K sh
Own +13%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$251.0K
50.0K sh · $5.02
Own -74%
-
Exercise·M
CHIEF MEDICAL OFFICER · 10b5-1
$97.0K
50.0K sh · $1.94
Own +278%
-
Exercise·M
CHIEF REGULATORY OFFICER · 10b5-1
$0
200.0K sh · 2 lots
Own +200%
-
Sell·S
CHIEF REGULATORY OFFICER · 10b5-1
$903.6K
200.0K sh · $4.52
Own -79%
-
Exercise·M
CHIEF REGULATORY OFFICER · 10b5-1
$381.0K
200.0K sh · $1.91 avg · 2 lots
Own +377%
-
Grant·A
Director
$0
76.9K sh
Own New
-
Grant·A
Hung David KEY
PRESIDENT AND CEO
$0
2.0M sh
Own New
-
Grant·A
Director
$0
74.8K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
748.1K sh
Own New
-
Grant·A
CHIEF REGULATORY OFFICER
$0
748.1K sh
Own New
-
Grant·A
CHIEF MEDICAL OFFICER
$0
748.1K sh
Own New
-
Grant·A
CHIEF PEOPLE OFFICER
$0
748.1K sh
Own New
-
Grant·A
Sauvage Philippe KEY
Chief Financial Officer
$0
748.1K sh
Own New
-
Grant·A
SEE REMARKS
$0
224.4K sh
Own New
-
Grant·A
SEE REMARKS
$0
50.8K sh
Own +292%
-
Grant·A
CHIEF TECHNICAL OPERATIONS
$0
748.1K sh
Own New
-
Grant·A
CHIEF SCIENTIFIC OFFICER
$0
748.1K sh
Own New
-
Exercise·M
CHIEF MEDICAL OFFICER
$0
150.0K sh
Own +1000%
-
Sell·S
CHIEF MEDICAL OFFICER
$1.2M
150.0K sh · $7.82
Own -89%
-
Exercise·M
CHIEF MEDICAL OFFICER
$439.5K
150.0K sh · $2.93
Own +833%
-
Exercise·M
CHIEF MEDICAL OFFICER
$0
20.0K sh · 2 lots
Own +4%
-
Exercise·M
CHIEF MEDICAL OFFICER
$72.2K
20.0K sh · $3.61 avg · 2 lots
Own +250%
-
Sell·S
CHIEF MEDICAL OFFICER
$155.0K
20.0K sh · $7.75 avg · 2 lots
Own -53%
-
Exercise·M
CHIEF MEDICAL OFFICER
$0
20.0K sh
Own +5%
-
Sell·S
CHIEF MEDICAL OFFICER
$140.0K
20.0K sh · $7.00
Own -53%
-
Exercise·M
CHIEF MEDICAL OFFICER
$37.4K
20.0K sh · $1.87
Own +111%
-
Exercise·M
CHIEF SCIENTIFIC OFFICER
$0
369.1K sh · 2 lots
Own New
-
Sell·S
CHIEF SCIENTIFIC OFFICER
$2.7M
369.1K sh · $7.23 avg · 2 lots
Own -100%
-
Exercise·M
CHIEF SCIENTIFIC OFFICER
$702.1K
369.1K sh · $1.90 avg · 2 lots
Own New
-
Exercise·M
CHIEF MEDICAL OFFICER
$0
30.0K sh · 2 lots
Own +7%
-
Sell·S
CHIEF MEDICAL OFFICER
$148.1K
30.0K sh · $4.94 avg · 2 lots
Own -62%
-
Exercise·M
CHIEF MEDICAL OFFICER
$56.1K
30.0K sh · $1.87 avg · 2 lots
Own New
-
Exercise·M
CHIEF TECHNICAL OPERATIONS
$0
200.0K sh
Own +200%
-
Sell·S
CHIEF TECHNICAL OPERATIONS
$1.4M
200.0K sh · $7.14
Own -89%
-
Exercise·M
CHIEF TECHNICAL OPERATIONS
$374.0K
200.0K sh · $1.87
Own +833%
-
Exercise·M
CHIEF SCIENTIFIC OFFICER · 10b5-1
$0
100.0K sh
Own +50%
-
Exercise·M
CHIEF SCIENTIFIC OFFICER · 10b5-1
$174.0K
100.0K sh · $1.74
Own New
-
Sell·S
CHIEF SCIENTIFIC OFFICER · 10b5-1
$502.0K
100.0K sh · $5.02
Own -100%
-
Other·G
Director
$0
700.0K sh · 2 lots
Own -64%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Mashal Robert | Buy P | 25.0K | $118.2K |
| May 21, 2026 | VERNON W ANTHONY | Grant A | 123.4K | $0 |
| May 21, 2026 | Mashal Robert | Grant A | 123.4K | $0 |
| May 21, 2026 | FALBERG KATHRYN E | Grant A | 123.4K | $0 |
| May 21, 2026 | Cui Xiangmin | Grant A | 123.4K | $0 |
| May 21, 2026 | Bazemore Robert B | Grant A | 123.4K | $0 |
| May 21, 2026 | BLICKENSTAFF KIM D | Grant A | 123.4K | $0 |
| Apr 17, 2026 | Wentworth Kerry 10b5-1 | Exercise M | 36.8K | $0 |
| Apr 17, 2026 | Wentworth Kerry 10b5-1 | Sell S | 36.8K | $184.3K |
| Apr 17, 2026 | Wentworth Kerry 10b5-1 | Exercise M | 36.8K | $107.7K |
| Apr 17, 2026 | Liu Dongfang 10b5-1 | Exercise M | 50.0K | $0 |
| Apr 17, 2026 | Liu Dongfang 10b5-1 | Sell S | 50.0K | $251.0K |
| Apr 17, 2026 | Liu Dongfang 10b5-1 | Exercise M | 50.0K | $97.0K |
| Apr 6, 2026 | Wentworth Kerry 10b5-1 | Exercise M | 200.0K2 lots | $0 |
| Apr 6, 2026 | Wentworth Kerry 10b5-1 | Sell S | 200.0K | $903.6K |
| Apr 6, 2026 | Wentworth Kerry 10b5-1 | Exercise M | 200.0K2 lots | $381.0K |
| Feb 27, 2026 | Cui Xiangmin | Grant A | 76.9K | $0 |
| Feb 27, 2026 | Hung David KEY | Grant A | 2.0M | $0 |
| Feb 27, 2026 | Cui Xiangmin | Grant A | 74.8K | $0 |
| Feb 27, 2026 | Sjogren Colleen | Grant A | 748.1K | $0 |
| Feb 27, 2026 | Wentworth Kerry | Grant A | 748.1K | $0 |
| Feb 27, 2026 | Liu Dongfang | Grant A | 748.1K | $0 |
| Feb 27, 2026 | Markel Stacy | Grant A | 748.1K | $0 |
| Feb 27, 2026 | Sauvage Philippe KEY | Grant A | 748.1K | $0 |
| Feb 27, 2026 | Makunje Moses | Grant A | 224.4K | $0 |
| Feb 27, 2026 | Makunje Moses | Grant A | 50.8K | $0 |
| Feb 27, 2026 | Hanley David C. | Grant A | 748.1K | $0 |
| Feb 27, 2026 | Hattersley Gary | Grant A | 748.1K | $0 |
| Dec 1, 2025 | Liu Dongfang | Exercise M | 150.0K | $0 |
| Dec 1, 2025 | Liu Dongfang | Sell S | 150.0K | $1.2M |
| Dec 1, 2025 | Liu Dongfang | Exercise M | 150.0K | $439.5K |
| Nov 26, 2025 | Liu Dongfang | Exercise M | 20.0K2 lots | $0 |
| Nov 26, 2025 | Liu Dongfang | Exercise M | 20.0K2 lots | $72.2K |
| Nov 26, 2025 | Liu Dongfang | Sell S | 20.0K2 lots | $155.0K |
| Nov 20, 2025 | Liu Dongfang | Exercise M | 20.0K | $0 |
| Nov 20, 2025 | Liu Dongfang | Sell S | 20.0K | $140.0K |
| Nov 20, 2025 | Liu Dongfang | Exercise M | 20.0K | $37.4K |
| Nov 20, 2025 | Hattersley Gary | Exercise M | 369.1K2 lots | $0 |
| Nov 20, 2025 | Hattersley Gary | Sell S | 369.1K2 lots | $2.7M |
| Nov 20, 2025 | Hattersley Gary | Exercise M | 369.1K2 lots | $702.1K |
| Nov 19, 2025 | Liu Dongfang | Exercise M | 30.0K2 lots | $0 |
| Nov 19, 2025 | Liu Dongfang | Sell S | 30.0K2 lots | $148.1K |
| Nov 19, 2025 | Liu Dongfang | Exercise M | 30.0K2 lots | $56.1K |
| Nov 19, 2025 | Hanley David C. | Exercise M | 200.0K | $0 |
| Nov 19, 2025 | Hanley David C. | Sell S | 200.0K | $1.4M |
| Nov 19, 2025 | Hanley David C. | Exercise M | 200.0K | $374.0K |
| Oct 27, 2025 | Hattersley Gary 10b5-1 | Exercise M | 100.0K | $0 |
| Oct 27, 2025 | Hattersley Gary 10b5-1 | Exercise M | 100.0K | $174.0K |
| Oct 27, 2025 | Hattersley Gary 10b5-1 | Sell S | 100.0K | $502.0K |
| Aug 11, 2025 | Mashal Robert | Other G | 700.0K2 lots | $0 |
Buy Sell Non-market (grant · exercise · gift)
About NUVB insider trading
This page tracks insider transactions for Nuvation Bio Inc. (NUVB) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.